Quantum量子訊息有限公司

AI-Enabled Home Ventilation Market

完整報告名稱與涵蓋範圍
AI-Enabled Home Ventilation Market Size, Share & Trends Analysis Report, By Device Type (Home Mechanical Ventilators (Life-Support and Non-Life-Support), Bilevel and Advanced Positive Airway Pressure Devices, Portable and Travel Ventilators, Connected Platforms, AI Analytics and Remote Monitoring Software), By Ventilation Mode (Non-Invasive Ventilation, Invasive Ventilation via Tracheostomy), By Indication (COPD and Chronic Hypercapnic Respiratory Failure, Neuromuscular and Restrictive Disorders, Obesity Hypoventilation and Complex Sleep-Disordered Breathing, Pediatric and Chronic Respiratory Conditions), By End User, By Region, and Segment Forecasts, 2026-2035

報告摘要

The AI-enabled home ventilation market covers home mechanical ventilators, bilevel and advanced positive airway pressure devices, portable and travel ventilators and the connected platforms, AI analytics and remote monitoring software that adapt therapy and support clinical management for patients with chronic respiratory failure, neuromuscular disease, obesity hypoventilation and pediatric conditions. Hospital critical care ventilators and standard sleep apnea therapy devices are excluded. Home ventilation is expanding as hospitals discharge ventilator-dependent patients earlier, as evidence supports home non-invasive ventilation for hypercapnic COPD and as ageing and neuromuscular populations grow. Manufacturers are embedding adaptive algorithms that adjust pressure support and backup rates to patient physiology, cloud connectivity that transmits usage and leak data, and AI analytics that flag deterioration and prioritise clinical outreach, enabling home care providers to manage larger caseloads with fewer visits. Reimbursement reforms that distinguish life-support from non-life-support devices, competitive bidding, recalls that reshaped supplier shares and cybersecurity requirements for connected devices are shaping competition, while remote monitoring reimbursement supports service-based models. North America and Europe lead adoption, with Japan, Australia and China expanding home ventilation programs. Competition involves respiratory therapy leaders, dedicated home ventilator specialists, critical care ventilator manufacturers and Asian device producers. The InsightAce study includes revenue forecasts in US$ for all device type, ventilation mode, indication and end user and regional segments across 2026-2035, segment-level trend analysis, competitive positioning assessment and company profiles.

授權報價

Single User$4,500 USD
Enterprise / Global Site Licence$9,500 USD

目錄 Table of Contents

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global AI-Enabled Home Ventilation Market Snapshot Chapter 4. Global AI-Enabled Home Ventilation Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Market Drivers 4.3. Market Challenges 4.4. Emerging Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis - Porter's Five Forces Analysis 4.7. Competitive Landscape and Market Positioning 4.8. Market Opportunity Analysis Chapter 5. Market Segmentation 1: By Device Type Estimates & Trend Analysis 5.1. Device Type & Market Share, 2026 & 2035 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Device Type: 5.2.1. Home Mechanical Ventilators (Life-Support and Non-Life-Support) 5.2.2. Bilevel and Advanced Positive Airway Pressure Devices 5.2.3. Portable and Travel Ventilators 5.2.4. Connected Platforms, AI Analytics and Remote Monitoring Software Chapter 6. Market Segmentation 2: By Ventilation Mode Estimates & Trend Analysis 6.1. Ventilation Mode & Market Share, 2026 & 2035 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Ventilation Mode: 6.2.1. Non-Invasive Ventilation 6.2.2. Invasive Ventilation via Tracheostomy Chapter 7. Market Segmentation 3: By Indication Estimates & Trend Analysis 7.1. Indication & Market Share, 2026 & 2035 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Indication: 7.2.1. COPD and Chronic Hypercapnic Respiratory Failure 7.2.2. Neuromuscular and Restrictive Disorders 7.2.3. Obesity Hypoventilation and Complex Sleep-Disordered Breathing 7.2.4. Pediatric and Chronic Respiratory Conditions Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis 8.1. End User & Market Share, 2026 & 2035 8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User: 8.2.1. Home Care and Durable Medical Equipment Providers 8.2.2. Hospitals and Discharge Programs 8.2.3. Long-Term Care and Skilled Nursing Facilities Chapter 9. AI-Enabled Home Ventilation Market: Regional Estimates & Trend Analysis 9.1. North America 9.1.1. United States 9.1.2. Canada 9.2. Europe 9.2.1. Germany 9.2.2. United Kingdom 9.2.3. France 9.2.4. Italy 9.2.5. Spain 9.2.6. Rest of Europe 9.3. Asia Pacific 9.3.1. China 9.3.2. Japan 9.3.3. India 9.3.4. South Korea 9.3.5. Australia 9.3.6. Southeast Asia 9.3.7. Rest of Asia Pacific 9.4. Latin America 9.4.1. Brazil 9.4.2. Mexico 9.4.3. Rest of Latin America 9.5. Middle East & Africa 9.5.1. GCC Countries 9.5.2. South Africa 9.5.3. Rest of Middle East & Africa Chapter 10. Competitive Landscape 10.1. Company Market Positioning Analysis 10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A) Chapter 11. Company Profiles 11.1. ResMed Inc. 11.2. Philips (Respironics) 11.3. Breas Medical AB 11.4. Lowenstein Medical Technology GmbH & Co. KG 11.5. Vyaire Medical (Zoll Medical Corporation) 11.6. Ventec Life Systems (React Health) 11.7. Fisher & Paykel Healthcare Corporation Limited 11.8. Nihon Kohden Corporation 11.9. BMC Medical Co., Ltd. 11.10. Medtronic plc 11.11. Drager AG & Co. KGaA 11.12. Air Liquide Healthcare 11.13. Hamilton Medical AG 11.14. Yuwell (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.) 11.15. Ventinova Medical B.V.

圖表清單 List of Tables & Figures

Table 1. Global AI-Enabled Home Ventilation Market Revenue Forecast by Device Type, 2026-2035 (US$ Mn) Figure 1. Global AI-Enabled Home Ventilation Market Segmentation Overview Table 2. Global AI-Enabled Home Ventilation Market Revenue Forecast by Ventilation Mode, 2026-2035 (US$ Mn) Figure 2. Global AI-Enabled Home Ventilation Market Share by Device Type, 2026 & 2035 Table 3. Global AI-Enabled Home Ventilation Market Revenue Forecast by Indication, 2026-2035 (US$ Mn) Figure 3. Home Ventilation Patient Population and Device Demand by Indication, 2026-2035 Table 4. Global AI-Enabled Home Ventilation Market Revenue Forecast by End User, 2026-2035 (US$ Mn) Figure 4. Global AI-Enabled Home Ventilation Market Share by Ventilation Mode, 2026 & 2035 Table 5. North America AI-Enabled Home Ventilation Market Revenue by Country, 2026-2035 (US$ Mn) Figure 5. Adaptive Algorithms and Remote Monitoring Features Across Home Ventilator Platforms Table 6. Europe AI-Enabled Home Ventilation Market Revenue by Country, 2026-2035 (US$ Mn) Figure 6. Asia Pacific AI-Enabled Home Ventilation Growth Opportunity Analysis Table 7. Asia Pacific AI-Enabled Home Ventilation Market Revenue by Country, 2026-2035 (US$ Mn) Figure 7. Reimbursement Frameworks for Home Ventilation and Remote Monitoring by Region Table 8. Latin America AI-Enabled Home Ventilation Market Revenue by Country, 2026-2035 (US$ Mn) Figure 8. Competitive Positioning of Key AI-Enabled Home Ventilation Market Participants Table 9. Middle East & Africa AI-Enabled Home Ventilation Market Revenue by Country, 2026-2035 (US$ Mn)

提及公司

ResMed Inc.Philips (Respironics)Breas Medical ABLowenstein Medical Technology GmbH & Co. KGVyaire Medical (Zoll Medical Corporation)Ventec Life Systems (React Health)Fisher & Paykel Healthcare Corporation LimitedNihon Kohden CorporationBMC Medical Co., Ltd.Medtronic plcDrager AG & Co. KGaAAir Liquide HealthcareHamilton Medical AGYuwell (Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.)Ventinova Medical B.V.

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們